Literature DB >> 30409291

Non-smoking, non-drinking elderly females, a 5 year follow-up of a clinically distinct cohort of oral squamous cell carcinoma patients.

Adrian DeAngelis1, Omar Breik2, Kendrick Koo3, Tim Iseli3, Alf Nastri4, Tsien Fua5, Danny Rischin6, Michael McCullough7, David Wiesenfeld8.   

Abstract

To examine differences in survival and clinical outcomes of elderly patients without traditional risk factors presenting with oral squamous cell carcinoma. Retrospective review of 287 consecutive patients divided into 2 treatment period cohorts treated for oral SCC between the 1st Jan 2007 and 31st Dec 2012. Patients were classified as either smoker-drinkers (SD) or non-smoking, non-drinking (NSND). Only patients with oral sub-site primaries according to ICD-10 were included. Carcinomas of the lip, tonsil, base of tongue and oro-pharyngeal subsites were excluded. Of the study population (N = 287), 24.4% were NSND and 9.75% were NSND elderly (older than 70 years) females. >50% of tumours arose from the oral tongue in NSND patients (p = 0.022) and there was a higher rate of recurrent and persistent disease (42.9% vs 27.6%, p = 0.005). Disease specific survival at 5 years was significantly reduced when NSND elderly females were compared to all other patients (p < 0.001) as well as age matched controls (p = 0.006). This effect was verified independently in each cohort.The results of this study suggest that NSND elderly females are a distinct patient population with poorer disease specific survival outcomes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Elderly females; Head and neck cancer; Non-drinking; Non-smoking; Oral cancer; Squamous cell carcinoma

Year:  2018        PMID: 30409291     DOI: 10.1016/j.oraloncology.2018.09.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

1.  Epidemiological, Clinical, and Oncological Outcomes of non-Alcohol Drinking and non-Smoking Laryngeal Squamous Cell Carcinoma Patients: A Distinct Entity.

Authors:  Qiang Huang; Yang Guo; Yujie Shen; Chi-Yao Hsueh; Lei Tao; Ming Zhang; Chunping Wu; Hongli Gong; Liang Zhou
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Arguments to Support a Viral Origin of Oral Squamous Cell Carcinoma in Non-Smoker and Non-Drinker Patients.

Authors:  Jean-Philippe Foy; Chloé Bertolus; David Boutolleau; Henri Agut; Antoine Gessain; Zdenko Herceg; Pierre Saintigny
Journal:  Front Oncol       Date:  2020-05-21       Impact factor: 6.244

3.  Clinicopathological characteristics of young never smoker females with oral cavity squamous cell carcinoma: A STROBE compliant retrospective observational study.

Authors:  Minsu Kwon; Dong Kyu Lee; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim; Yoon Se Lee
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

4.  Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far?

Authors:  Sophia Uddin; Alka Singh; Vasudha Mishra; Nishant Agrawal; Zhen Gooi; Evgeny Izumchenko
Journal:  Oncol Rev       Date:  2022-02-22

5.  Relationship between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea.

Authors:  Jin-Sung Yuk; Bo Young Kim
Journal:  J Clin Med       Date:  2022-10-02       Impact factor: 4.964

6.  Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients.

Authors:  Kendrick Koo; Dmitri Mouradov; Christopher M Angel; Tim A Iseli; David Wiesenfeld; Michael J McCullough; Antony W Burgess; Oliver M Sieber
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

7.  Characteristics and outcome differences in male and female oral cavity cancer patients in Taiwan.

Authors:  Yi-Chieh Lee; Chi-Kuang Young; Huei-Tzu Chien; Shy-Chyi Chin; Andrea Iandelli; Chun-Ta Liao; Chung-Kang Tsao; Chung-Jan Kang; Shiang-Fu Huang
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.